The proceedings from "The Cutting Edge" symposium are now available:

• Word (.doc) format (3.5 MB)
• Adobe Acrobat (.pdf) format - (439 KB)
  • Titles include:
  • Drug discovery: computer aided drug design, Kathy E. Mitchell
  • Drug discovery: antibacterial peptides, Frank Blecha
  • Drug discovery: targets for CNS disorders, Geoffrey Varta
  • Pharmacokinetics in drug development: beyond simple models, Pierre-Louis Toutain
  • Evaluating variability in drug response: pharmacogenetics, Herve LeFebvre
  • Monitoring of responses: pharmacovigilance, Mark Novotny
  • Metabolism: the cytochrome p450s of dogs, Lauren Trepanier and Alastair Cribb
  • Metabolism: In vitro techniques to investigate small animal drug metabolism, Jane Owens-Clark
  • The role of genomics in drug discovery, Carla Chieffo
  • Implications of drug-protein binding and the occurrence of drug-drug interactions, Betty-Ann Hoener
  • COX1, COX2, COX3: relevance to pain management, Steve Budsberg
  • New therapeutic horizons: transdermal drug delivery, Katrina Mealey
  • New therapeutic horizons: novel drug delivery methods, Gijsbert Van Der Wijdeven
  • New therapeutic horizons: peptide drug delivery, Mark Jones
  • New therapeutic horizons: erythropoeitin, Mark Walker
  • New therapeutic horizons: choosing a new drug for inducing anesthesia: propofol or alfaxalone? Martin Pearson
  • New therapeutic horizons: fluoxetine pharmacology, safety, and use in cats and dogs and its role in behavior modification, Kirby Pasloske
  • AAVPT Position Paper:Post-exposure management and treatment of anthrax in dogs, Executive Council of the American Academy of Veterinary Pharmacology and Therapeutics

AAVPT would like to thank the symposium's sponsors for their generous support of this event.

See the list of sponsors in Word (2.9 MB) or Acrobat (1 KB) format.